$EPC

EDGEWELL PERSONAL CARE Co (EPC): Results of Operations and Financial Condition

EDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q3fy26-epcexhibit991.htm EX-99.1 Document Exhibit 99.1 Edgewell Personal Care Company 6 Research Drive Shelton, Conn 06484 FOR IMMEDIATE RELEASE Company Contact Chris Gough Vice President, Investor Relations 203-944-5706 Chris.Gough@Edgewell.com Edgewell Personal Care A

Original reporting
Published Aug 5, 2026, 10:10 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 10:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$EPC
Neutral
medium confidence
Mentioned
$EPC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$EPCNeutralMed
01

Why it matters

Traders can update models for Edgewell’s near-term trajectory using the reported organic sales trend, North America improvement, margin movements, restructuring costs, and the company’s statement that the full-year outlook was narrowed while adjusted EPS and adjusted EBITDA midpoints were unchanged.

02

Market read

Organic net sales returned to growth and North America improved meaningfully, but gross margin declined and GAAP EPS dropped year over year; the company also narrowed its full-year outlook.

03

What to watch

International organic sales declined due to temporary disruptions and manufacturing consolidation; investors may discount the improvement as non-recurring while focusing on tariff and mix headwinds.

Relevance 7/10Novelty 7/10Timing: pre-market today (SEC 8-K filed Aug 5, 2026)

Background

This is an SEC Form 8-K with Exhibit 99.1 reporting Edgewell Personal Care’s third fiscal quarter 2026 results ended June 30, 2026, excluding the Feminine Care business treated as discontinued operations.

Company-level read

Ticker impact

$EPCNeutralMedium confidence
Context

Edgewell reported Q3 FY2026 results, with organic net sales returning to growth and adjusted EPS flat at $0.72, plus a narrowed full-year outlook.

Expected impact

Near-term trading likely hinges on how investors interpret the narrowed outlook versus margin compression and GAAP EPS decline.

Evidence & confidence

The filing provides multiple decision-relevant datapoints (organic sales trend, North America improvement, gross margin down 210 bps, restructuring costs, and full-year outlook narrowed) but the excerpt does not include the specific outlook numbers, limiting precision on magnitude.

Market effects

Personal care peers may see read-across on demand durability and margin sensitivity to tariffs, mix, and promotional levels.

North America execution improvement could support sentiment for brands with similar distribution and category exposure.

International weakness tied to Middle East conflict and supply chain disruption highlights ongoing geopolitical and logistics risks for consumer staples.

Counterpoint

The headline growth is modest and gross margin fell materially, suggesting the earnings quality may be weaker than the organic sales rebound implies.

Key entities

  • Edgewell Personal Care Company

    NYSE-listed personal care company reporting Q3 FY2026 results and a narrowed full-year outlook.

  • Feminine Care divestiture

    Divestiture proceeds reduced revolving credit facility borrowings, lowering interest expense in the quarter.

  • U.S. revolving credit facility

    Provided additional liquidity of $418.8 million under the facility as of quarter end.

Related articles

$EPCMedAI 8/10

Edgewell Personal Care Q3 Earnings Call Highlights

Edgewell Personal Care (EPC) reported Q3 organic sales trends: wet shave organic sales fell 1.9% as private-label supply disruptions outweighed branded growth, while U.S. razors and blades consumption rose with higher promotions. Sun and skin care organic sales rose 5%. Adjusted operating income was $53M (9.3% margin); GAAP EPS $0.26 vs $0.46. Fiscal 2026 adjusted EPS guidance is $1.80-$2.00.

$EPCMed

Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results

Edgewell Personal Care (NYSE: EPC) reported fiscal 2026 third-quarter results ended June 30, 2026. Net sales rose 1.7% to $570.1M, with organic sales up 1.1%. Adjusted EPS was $0.72, flat year over year, while GAAP diluted EPS was $0.26. The company said full-year outlook was narrowed, with adjusted EPS and EBITDA midpoints unchanged, and declared a $0.15 dividend.

$EPCMedAI 8/10

Why Is Edgewell Personal Care (EPC) Stock Soaring Today

Edgewell Personal Care (EPC) shares rose 13.7% in the afternoon after the company rejected an unsolicited takeover offer from private equity firm Yellow Wood Partners, priced at $30 per share, according to reports. The board reportedly viewed the bid as too low. The stock is up 55.6% year-to-date and trades near its 52-week high.

$MUMed

Stocks making the biggest moves midday: Micron Technology, SpaceX, IBM, Flex & more

Midday movers: Micron fell over 10% amid a broader tech selloff; Marvell slid 8% and Sandisk dropped 11%. Accenture rose nearly 2% after raising its buyback by $2B to over $7B. Flex fell over 2% after COO sold 36,000 shares. IBM gained over 4% after a JPMorgan overweight upgrade. Carnival dropped 6% on weaker Q3 guidance. AMC sank 25% on a planned 95.3M-share sale.

$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.

$WTIMed

W&T Offshore Q2 Earnings Call Highlights

W&T Offshore (WTI) reported Q2 realized oil-equivalent prices of $50.23/bbl, up 11% from Q1 and about 40% vs year-end 2025. It forecast Q3 production above 35,000 boe/d midpoint. Q2 LOE was $72M and capex $10.4M. Full-year 2026 capex guidance is $20M-$25M. Management discussed surety litigation and potential damages.